{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,26]],"date-time":"2026-09-26T05:26:00Z","timestamp":1790400360588,"version":"4.1.0"},"reference-count":104,"publisher":"Oxford University Press (OUP)","issue":"1","license":[{"start":{"date-parts":[[2014,1,1]],"date-time":"2014-01-01T00:00:00Z","timestamp":1388534400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["ecco-jccjournal.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2014,1,1]]},"DOI":"10.1016\/j.crohns.2013.04.006","type":"journal-article","created":{"date-parts":[[2013,5,27]],"date-time":"2013-05-27T20:15:15Z","timestamp":1369685715000},"page":"31-44","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":128,"title":["Extra-intestinal malignancies in inflammatory bowel disease: Results of the 3rd ECCO Pathogenesis Scientific Workshop (III)"],"prefix":"10.1093","volume":"8","author":[{"given":"Fernando","family":"Magro","sequence":"first","affiliation":[{"name":"Gastroenterology Department, Centro Hospitalar S. Jo\u00e3o, Institute of Pharmacology and Therapeutics, Faculty of Medicine, University of Porto, Porto, Portugal"},{"name":"Institute for Molecular and Cell Biology, University of Porto, Porto, Portugal"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laurent","family":"Peyrin-Biroulet","sequence":"additional","affiliation":[{"name":"Inserm U954 and Department of Hepato-Gastroenterology, University Hospital of Nancy, and Universit\u00e9 Henri Poincar\u00e9 1,Vandoeuvre-l\u00e8s-Nancy, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Harry","family":"Sokol","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology, AP-HP, H\u00f4pital Saint-Antoine F-75012 and ERL 1057 INSERM\/UMRS 7203, UPMC Univ Paris 06F-75005, Paris, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xavier","family":"Aldeger","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology of University Hospital Doctor Josep Trueta de Girona, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonia","family":"Costa","sequence":"additional","affiliation":[{"name":"Department of Gynecology and Obstetrics Department, Centro Hospitalar S. Jo\u00e3o, Portugal, and Faculty of Medicine, Porto University, Porto, Portugal"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter D.","family":"Higgins","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, University of Michigan Medical School, Ann Arbor, MI, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joel C.","family":"Joyce","sequence":"additional","affiliation":[{"name":"Department of Dermatology, Medical College of Wisconsin, WI, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Konstantinos H.","family":"Katsanos","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine & Hepato-Gastroenterology Unit, Medical School University of Ioannina, Ioannina, Greece"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anthony","family":"Lopez","sequence":"additional","affiliation":[{"name":"Inserm U954 and Department of Hepato-Gastroenterology, University Hospital of Nancy, and Universit\u00e9 Henri Poincar\u00e9 1,Vandoeuvre-l\u00e8s-Nancy, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Teresa Mas","family":"de Xaxars","sequence":"additional","affiliation":[{"name":"Departement of Biology, University of Girona, Girona, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elena","family":"Toader","sequence":"additional","affiliation":[{"name":"Gastroenterology and Hepatology Center, University Hospital Sf. Spiridon, and University of Medicine and Pharmacy Gr. T. Popa, Iasi, Romania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laurent","family":"Beaugerie","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology, AP-HP, H\u00f4pital Saint-Antoine F-75012 and ERL 1057 INSERM\/UMRS 7203, UPMC Univ Paris 06F-75005, Paris, France"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2014,1,1]]},"reference":[{"key":"key\n\t\t\t\t2018110508353551000_bb0005","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1002\/cncr.20288","article-title":"Annual report to the nation on the status of cancer, 1975-2001, with a special feature regarding survival","volume":"101","author":"Jemal","year":"2004","journal-title":"Cancer"},{"key":"key\n\t\t\t\t2018110508353551000_bb0010","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1080\/02841860500531682","article-title":"Epidemiology and etiology of non-Hodgkin lymphoma\u2013a review","volume":"45","author":"Ekstrom-Smedby","year":"2006","journal-title":"Acta Oncol"},{"key":"key\n\t\t\t\t2018110508353551000_bb0015","doi-asserted-by":"crossref","first-page":"1617","DOI":"10.1016\/S0140-6736(09)61302-7","article-title":"Lymphoproliferative disorders in patients receiving thiopurines for inflammatory bowel disease: a prospective observational cohort study","volume":"374","author":"Beaugerie","year":"2009","journal-title":"Lancet"},{"key":"key\n\t\t\t\t2018110508353551000_bb0020","doi-asserted-by":"crossref","first-page":"2015","DOI":"10.1002\/1097-0142(19910401)67:7<2015::AID-CNCR2820670731>3.0.CO;2-R","article-title":"Extracolonic malignancies in inflammatory bowel disease","volume":"67","author":"Ekbom","year":"1991","journal-title":"Cancer"},{"key":"key\n\t\t\t\t2018110508353551000_bb0025","doi-asserted-by":"crossref","first-page":"1080","DOI":"10.1053\/gast.2001.28703","article-title":"Inflammatory bowel disease is not associated with an increased risk of lymphoma","volume":"121","author":"Lewis","year":"2001","journal-title":"Gastroenterology"},{"key":"key\n\t\t\t\t2018110508353551000_bb0030","doi-asserted-by":"crossref","first-page":"2308","DOI":"10.1111\/j.1572-0241.2000.02316.x","article-title":"Risk of lymphoma in inflammatory bowel disease","volume":"95","author":"Loftus","year":"2000","journal-title":"Am J Gastroenterol"},{"key":"key\n\t\t\t\t2018110508353551000_bb0035","doi-asserted-by":"crossref","first-page":"1028","DOI":"10.1080\/10428190801911662","article-title":"Immune surveillance of EBV-infected B cells and the development of non-Hodgkin lymphomas in immunocompromised patients","volume":"49","author":"Pietersma","year":"2008","journal-title":"Leuk Lymphoma"},{"key":"key\n\t\t\t\t2018110508353551000_bb0040","doi-asserted-by":"crossref","first-page":"1165","DOI":"10.1182\/blood.V97.5.1165","article-title":"Frequent monitoring of Epstein-Barr virus DNA load in unfractionated whole blood is essential for early detection of posttransplant lymphoproliferative disease in high-risk patients","volume":"97","author":"Stevens","year":"2001","journal-title":"Blood"},{"key":"key\n\t\t\t\t2018110508353551000_bb0045","doi-asserted-by":"crossref","first-page":"1917","DOI":"10.1002\/ijc.23722","article-title":"Incidence and mortality from non-Hodgkin lymphoma in Europe: the end of an epidemic?","volume":"123","author":"Bosetti","year":"2008","journal-title":"Int J Cancer"},{"key":"key\n\t\t\t\t2018110508353551000_bb0050","doi-asserted-by":"crossref","first-page":"1427","DOI":"10.1136\/gut.2009.181982","article-title":"Inflammatory bowel disease and lymphoproliferative disorders: the dust is starting to settle","volume":"58","author":"Sokol","year":"2009","journal-title":"Gut"},{"key":"key\n\t\t\t\t2018110508353551000_bb0055","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1002\/art.21675","article-title":"Association of chronic inflammation, not its treatment, with increased lymphoma risk in rheumatoid arthritis","volume":"54","author":"Baecklund","year":"2006","journal-title":"Arthritis Rheum"},{"key":"key\n\t\t\t\t2018110508353551000_bb0060","doi-asserted-by":"crossref","first-page":"620","DOI":"10.1038\/sj.leu.2405059","article-title":"Cell origin of pyothorax-associated lymphoma: a lymphoma strongly associated with Epstein-Barr virus infection","volume":"22","author":"Takakuwa","year":"2008","journal-title":"Leukemia"},{"issue":"11","key":"key\n\t\t\t\t2018110508353551000_bb0065","doi-asserted-by":"crossref","first-page":"2063","DOI":"10.1002\/ibd.22889","article-title":"Excess primary intestinal lymphoproliferative disorders in patients with inflammatory bowel disease","volume":"18","author":"Sokol","year":"2012","journal-title":"Inflamm Bowel Dis"},{"key":"key\n\t\t\t\t2018110508353551000_bb0070","doi-asserted-by":"crossref","first-page":"822","DOI":"10.1182\/blood-2003-11-3938","article-title":"Defective DNA mismatch repair in acute myeloid leukemia\/myelodysplastic syndrome after organ transplantation","volume":"104","author":"Offman","year":"2004","journal-title":"Blood"},{"key":"key\n\t\t\t\t2018110508353551000_bb0075","doi-asserted-by":"crossref","first-page":"1121","DOI":"10.1136\/gut.2004.049460","article-title":"Increased risk of lymphoma among inflammatory bowel disease patients treated with azathioprine and 6-mercaptopurine","volume":"54","author":"Kandiel","year":"2005","journal-title":"Gut"},{"key":"key\n\t\t\t\t2018110508353551000_bb0080","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1053\/gast.2002.30328","article-title":"Epstein-Barr virus-positive lymphoma in patients with inflammatory bowel disease treated with azathioprine or 6-mercaptopurine","volume":"122","author":"Dayharsh","year":"2002","journal-title":"Gastroenterology"},{"key":"key\n\t\t\t\t2018110508353551000_bb0085","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1136\/gut.36.2.311","article-title":"Fatal infectious mononucleosis: a severe complication in the treatment of Crohn's disease with azathioprine","volume":"36","author":"Posthuma","year":"1995","journal-title":"Gut"},{"key":"key\n\t\t\t\t2018110508353551000_bb0090","doi-asserted-by":"crossref","first-page":"1639","DOI":"10.1136\/gut.2008.163279","article-title":"Hepatosplenic T cell lymphoma in inflammatory bowel disease","volume":"57","author":"Shale","year":"2008","journal-title":"Gut"},{"key":"key\n\t\t\t\t2018110508353551000_bb0095","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/j.cgh.2010.09.016","article-title":"A systematic review of factors that contribute to hepatosplenic T-cell lymphoma in patients with inflammatory bowel disease","volume":"9","author":"Kotlyar","year":"2011","journal-title":"Clin Gastroenterol Hepatol"},{"key":"key\n\t\t\t\t2018110508353551000_bb0100","doi-asserted-by":"crossref","first-page":"363","DOI":"10.3109\/10428199509054421","article-title":"Immunosuppression-associated lymphoproliferative disorders in rheumatic patients","volume":"16","author":"Kamel","year":"1995","journal-title":"Leuk Lymphoma"},{"key":"key\n\t\t\t\t2018110508353551000_bb0105","doi-asserted-by":"crossref","first-page":"3909","DOI":"10.1182\/blood.V99.11.3909","article-title":"Lymphomas in rheumatoid arthritis patients treated with methotrexate: a 3-year prospective study in France","volume":"99","author":"Mariette","year":"2002","journal-title":"Blood"},{"key":"key\n\t\t\t\t2018110508353551000_bb0110","doi-asserted-by":"crossref","first-page":"1895","DOI":"10.1136\/ard.2010.149419","article-title":"Malignancies associated with tumour necrosis factor inhibitors in registries and prospective observational studies: a systematic review and meta-analysis","volume":"70","author":"Mariette","year":"2011","journal-title":"Ann Rheum Dis"},{"key":"key\n\t\t\t\t2018110508353551000_bb0115","doi-asserted-by":"crossref","first-page":"1409","DOI":"10.1038\/ajg.2012.218","article-title":"Serious infection and mortality in patients with Crohn's disease: more than 5 years of follow-up in the TREAT registry","volume":"107","author":"Lichtenstein","year":"2012","journal-title":"Am J Gastroenterol"},{"key":"key\n\t\t\t\t2018110508353551000_bb0120","doi-asserted-by":"crossref","first-page":"1648","DOI":"10.1111\/j.1600-6143.2007.01823.x","article-title":"Preemptive therapy of EBV-related lymphoproliferative disease after pediatric haploidentical stem cell transplantation","volume":"7","author":"Comoli","year":"2007","journal-title":"Am J Transplant"},{"key":"key\n\t\t\t\t2018110508353551000_bb0125","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1097\/00054725-200403000-00004","article-title":"Epstein-Barr virus viral load in Crohn's disease: effect of immunosuppressive therapy","volume":"10","author":"Reijasse","year":"2004","journal-title":"Inflamm Bowel Dis"},{"key":"key\n\t\t\t\t2018110508353551000_bb0130","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.crohns.2009.02.010","article-title":"European evidence-based Consensus on the prevention, diagnosis and management of opportunistic infections in inflammatory bowel disease","volume":"3","author":"Rahier","year":"2009","journal-title":"J Crohn's Colitis"},{"key":"key\n\t\t\t\t2018110508353551000_bb0135","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1056\/NEJM199409293311321","article-title":"Reversible lymphoma in the setting of azathioprine therapy for Crohn's disease","volume":"331","author":"Larvol","year":"1994","journal-title":"N Engl J Med"},{"key":"key\n\t\t\t\t2018110508353551000_bb0140","first-page":"S3","article-title":"HPV and cervical cancer in the world","volume":"26","author":"Castellsague","year":"2007","journal-title":"Vaccine"},{"key":"key\n\t\t\t\t2018110508353551000_bb0145","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1016\/S1470-2045(01)00486-7","article-title":"Global cancer statistics in the year 2000","volume":"2","author":"Parkin","year":"2001","journal-title":"Lancet Oncol"},{"key":"key\n\t\t\t\t2018110508353551000_bb0150","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1136\/jcp.55.4.244","article-title":"The causal relation between human papillomavirus and cervical cancer","volume":"55","author":"Bosch","year":"2002","journal-title":"J Clin Pathol"},{"key":"key\n\t\t\t\t2018110508353551000_bb0155","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1016\/j.virol.2008.11.046","article-title":"Papillomaviruses in the causation of human cancers - a brief historical account","volume":"384","author":"zur Hausen","year":"2009","journal-title":"Virology"},{"key":"key\n\t\t\t\t2018110508353551000_bb0160","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1056\/NEJM199802123380703","article-title":"Natural history of cervicovaginal papillomavirus infection in young women","volume":"338","author":"Ho","year":"1998","journal-title":"N Engl J Med"},{"key":"key\n\t\t\t\t2018110508353551000_bb0165","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1111\/j.1469-0691.2009.03032.x","article-title":"Human papilloma viruses and cancer in the post-vaccine era","volume":"15","author":"Galani","year":"2009","journal-title":"Clin Microbiol Infect"},{"issue":"Suppl. 3","key":"key\n\t\t\t\t2018110508353551000_bb0170","article-title":"Chapter 1: HPV in the etiology of human cancer","volume":"24","author":"Munoz","year":"2006","journal-title":"Vaccine"},{"key":"key\n\t\t\t\t2018110508353551000_bb0175","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/j.jcv.2006.12.009","article-title":"Review of current knowledge on HPV vaccination: An Appendix to the European Guidelines for Quality Assurance in Cervical Cancer Screening","volume":"38","author":"Arbyn","year":"2007","journal-title":"J Clin Virol"},{"key":"key\n\t\t\t\t2018110508353551000_bb0180","doi-asserted-by":"crossref","first-page":"931","DOI":"10.3748\/wjg.v11.i7.931","article-title":"Regulation of apoptosis by the papillomavirus E6 oncogene","volume":"11","author":"Litt","year":"2005","journal-title":"World J Gastroenterol"},{"key":"key\n\t\t\t\t2018110508353551000_bb0185","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1002\/path.1866","article-title":"HPV-mediated cervical carcinogenesis: concepts and clinical implications","volume":"208","author":"Snijders","year":"2006","journal-title":"J Pathol"},{"key":"key\n\t\t\t\t2018110508353551000_bb0190","doi-asserted-by":"crossref","first-page":"598","DOI":"10.1111\/j.1365-2036.2008.03766.x","article-title":"Screening differences and risk of cervical cancer in inflammatory bowel disease","volume":"28","author":"Hutfless","year":"2008","journal-title":"Aliment Pharmacol Ther"},{"key":"key\n\t\t\t\t2018110508353551000_bb0195","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1111\/j.1572-0241.2007.01582.x","article-title":"Higher Incidence of Abnormal Pap Smears in Women With Inflammatory Bowel Disease","volume":"103","author":"Kane","year":"2008","journal-title":"Am J Gastroenterol"},{"key":"key\n\t\t\t\t2018110508353551000_bb0200","doi-asserted-by":"crossref","first-page":"1621","DOI":"10.1002\/ibd.20959","article-title":"Lack of Association Between Cervical Dysplasia and IBD: A Large Case-Control Study","volume":"15","author":"Lees","year":"2009","journal-title":"Inflamm Bowel Dis"},{"key":"key\n\t\t\t\t2018110508353551000_bb0205","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1053\/j.gastro.2008.10.021","article-title":"Risk of Cervical Abnormalities in Women With Inflammatory Bowel Disease: A Population-Based Nested Case-Control Study","volume":"136","author":"Singh","year":"2009","journal-title":"Gastroenterology"},{"key":"key\n\t\t\t\t2018110508353551000_bb0210","doi-asserted-by":"crossref","first-page":"6167","DOI":"10.3748\/wjg.v12.i38.6167","article-title":"Abnormalities of uterine cervix in women with inflammatory bowel disease","volume":"12","author":"Bhatia","year":"2006","journal-title":"World J Gastroenterol"},{"key":"key\n\t\t\t\t2018110508353551000_bb0215","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1093\/rheumatology\/keq304","article-title":"Meta-analysis of systemic lupus erythematosus and the risk of cervical neoplasia","volume":"50","author":"Hongli","year":"2011","journal-title":"Rheumatology"},{"key":"key\n\t\t\t\t2018110508353551000_bb0220","doi-asserted-by":"crossref","first-page":"1485","DOI":"10.1177\/0961203310372952","article-title":"Are women with lupus at higher risk of HPV infection?","volume":"19","author":"Klumb","year":"2010","journal-title":"Lupus"},{"key":"key\n\t\t\t\t2018110508353551000_bb0225","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1177\/096120330000900711","article-title":"Increased cervical dysplasia in intravenous cyclophosphamide-treated patients with SLE: a preliminary study","volume":"9","author":"Bateman","year":"2000","journal-title":"Lupus"},{"key":"key\n\t\t\t\t2018110508353551000_bb0230","first-page":"1763","article-title":"Increased incidence of cervical intraepithelial neoplasia in women with systemic lupus erythematosus treated with intravenous cyclophosphamide","volume":"31","author":"Ognenovski","year":"2004","journal-title":"J Rheumatol"},{"key":"key\n\t\t\t\t2018110508353551000_bb0235","first-page":"94","article-title":"Abnormal cervicovaginal cytology in women with rheumatoid arthritis","volume":"78","author":"Mercado","year":"2010","journal-title":"Ginecol Obstet Mex"},{"key":"key\n\t\t\t\t2018110508353551000_bb0240","first-page":"876","article-title":"Cancers in cyclosporine-treated vs azathioprine-treated patients","volume":"28","author":"Penn","year":"1996","journal-title":"Transplant Proc"},{"key":"key\n\t\t\t\t2018110508353551000_bb0245","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1093\/ndt\/gfn607","article-title":"The uptake of cervical cancer screening by renal transplant recipients","volume":"24","author":"Courtney","year":"2009","journal-title":"Nephrol Dial Transplant"},{"key":"key\n\t\t\t\t2018110508353551000_bb0250","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1016\/j.jcv.2011.05.017","article-title":"Cervical Human Papillomavirus in transplanted Italian women: A long-term prospective follow-up study","volume":"51","author":"Origoni","year":"2011","journal-title":"J Clin Virol"},{"issue":"1","key":"key\n\t\t\t\t2018110508353551000_bb0255","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1186\/1743-422X-9-117","article-title":"Prevalence of high-risk human papillomavirus cervical infection in female kidney graft recipients: an observational study","volume":"9","author":"Pietrzak","year":"2012","journal-title":"Virol J"},{"key":"key\n\t\t\t\t2018110508353551000_bb0260","first-page":"410","article-title":"Cervical intraepithelial neoplasia and human papillomavirus related lesions of the genital tract in HIV positive and negative women","volume":"16","author":"Branca","year":"1995","journal-title":"Eur J Gynaecol Oncol"},{"key":"key\n\t\t\t\t2018110508353551000_bb0265","doi-asserted-by":"crossref","first-page":"1249","DOI":"10.1016\/S0140-6736(94)92150-4","article-title":"Long-term neoplasia risk after azathioprine treatment in inflammatory bowel disease","volume":"343","author":"Connell","year":"1994","journal-title":"Lancet"},{"key":"key\n\t\t\t\t2018110508353551000_bb0270","first-page":"8","article-title":"Determinants of female sexual function in inflammatory bowel disease: a survey based cross-sectional analysis","author":"Timmer","year":"2008","journal-title":"BMC Gastroenterol"},{"key":"key\n\t\t\t\t2018110508353551000_bb0275","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1016\/j.cgh.2008.10.007","article-title":"Suboptimal Rates of Cervical Testing Among Women With Inflammatory Bowel Disease","volume":"7","author":"Long","year":"2009","journal-title":"Clin Gastroenterol Hepatol"},{"key":"key\n\t\t\t\t2018110508353551000_bb0280","doi-asserted-by":"crossref","first-page":"1741","DOI":"10.1002\/ibd.21567","article-title":"Screening for Cervical and Breast Cancer Among Women with Inflammatory Bowel Disease: A Population-based Study","volume":"17","author":"Singh","year":"2011","journal-title":"Inflamm Bowel Dis"},{"key":"key\n\t\t\t\t2018110508353551000_bb0285","doi-asserted-by":"crossref","first-page":"810","DOI":"10.7326\/0003-4819-132-10-200005160-00009","article-title":"Accuracy of the Papanicolaou test in screening for and follow-up of cervical cytologic abnormalities: a systematic review","volume":"132","author":"Nanda","year":"2000","journal-title":"Ann Intern Med"},{"key":"key\n\t\t\t\t2018110508353551000_bb0290","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1093\/annonc\/mdp471","article-title":"European Guidelines for Quality Assurance in Cervical Cancer Screening. Second Edition-Summary Document","volume":"21","author":"Arbyn","year":"2010","journal-title":"Ann Oncol"},{"key":"key\n\t\t\t\t2018110508353551000_bb0295","first-page":"34","volume-title":"Off J Eur Union","author":"Council Recommendation of 2 December 2003 on Cancer Screening","year":"2003"},{"key":"key\n\t\t\t\t2018110508353551000_bb0300","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1093\/annonc\/mdg305","article-title":"European Code Against Cancer and scientific justification: third version (2003)","volume":"14","author":"Boyle","year":"2003","journal-title":"Ann Oncol"},{"key":"key\n\t\t\t\t2018110508353551000_bb0305","doi-asserted-by":"crossref","first-page":"342","DOI":"10.3322\/canjclin.52.6.342","article-title":"American Cancer Society guideline for the early detection of cervical neoplasia and cancer","volume":"52","author":"Saslow","year":"2002","journal-title":"CA Cancer J Clin"},{"key":"key\n\t\t\t\t2018110508353551000_bb0310","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1016\/S0140-6736(05)70937-5","article-title":"Cutaneous melanoma","volume":"365","author":"Thompson","year":"2005","journal-title":"Lancet"},{"key":"key\n\t\t\t\t2018110508353551000_bb0315","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1016\/S0140-6736(09)61196-X","article-title":"Non-melanoma skin cancer","volume":"375","author":"Madan","year":"2010","journal-title":"Lancet"},{"issue":"Suppl. 61","key":"key\n\t\t\t\t2018110508353551000_bb0320","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1046\/j.1365-2133.146.s61.2.x","article-title":"The epidemiology of skin cancer","volume":"146","author":"Diepgen","year":"2002","journal-title":"Br J Dermatol"},{"key":"key\n\t\t\t\t2018110508353551000_bb0325","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1007\/s11764-007-0009-y","article-title":"Melanoma survivorship: research opportunities","volume":"1","author":"Oliveria","year":"2007","journal-title":"J Cancer Surviv"},{"key":"key\n\t\t\t\t2018110508353551000_bb0330","first-page":"513","article-title":"Incidence of skin cancer in 5356 patients following organ transplantation","volume":"143","author":"Lindelof","year":"2000","journal-title":"Br J Dermatol"},{"key":"key\n\t\t\t\t2018110508353551000_bb0335","doi-asserted-by":"crossref","first-page":"1895","DOI":"10.1136\/ard.2010.149419","article-title":"Malignancies associated with tumour necrosis factor inhibitors in registries and prospective observational studies: a systematic review and meta-analysis","volume":"70","author":"Mariette","year":"1895","journal-title":"Ann Rheum Dis"},{"key":"key\n\t\t\t\t2018110508353551000_bb0340","doi-asserted-by":"crossref","first-page":"1621","DOI":"10.1053\/j.gastro.2011.06.050","article-title":"Increased risk for nonmelanoma skin cancers in patients who receive thiopurines for inflammatory bowel disease","volume":"141","author":"Peyrin-Biroulet","year":"2011","journal-title":"Gastroenterology"},{"key":"key\n\t\t\t\t2018110508353551000_bb0345","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1053\/j.gastro.2012.05.004","article-title":"Risk of melanoma and nonmelanoma skin cancer among patients with inflammatory bowel disease","volume":"143","author":"Long","year":"2012","journal-title":"Gastroenterology"},{"key":"key\n\t\t\t\t2018110508353551000_bb0350","doi-asserted-by":"crossref","first-page":"678","DOI":"10.1093\/jnci\/93.9.678","article-title":"Recent trends in cutaneous melanoma incidence among whites in the United States","volume":"93","author":"Jemal","year":"2001","journal-title":"J Natl Cancer Inst"},{"key":"key\n\t\t\t\t2018110508353551000_bb0355"},{"key":"key\n\t\t\t\t2018110508353551000_bb0360"},{"key":"key\n\t\t\t\t2018110508353551000_bb0365","first-page":"219","article-title":"Cutaneous melanoma","volume":"19\u201320","author":"Armstrong","year":"1994","journal-title":"Cancer Surv"},{"key":"key\n\t\t\t\t2018110508353551000_bb0370","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1634\/theoncologist.8-5-459","article-title":"The melanoma epidemic: res ipsa loquitur","volume":"8","author":"Beddingfield","year":"2003","journal-title":"Oncologist"},{"key":"key\n\t\t\t\t2018110508353551000_bb0375","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/S0190-9622(99)70185-4","article-title":"Skin cancer in kidney and heart transplant recipients and different long-term immunosuppressive therapy regimens","volume":"40","author":"Jensen","year":"1999","journal-title":"J Am Acad Dermatol"},{"key":"key\n\t\t\t\t2018110508353551000_bb0380","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1097\/00002030-199905070-00014","article-title":"Risk of cancer in people with AIDS","volume":"13","author":"Grulich","year":"1999","journal-title":"AIDS"},{"key":"key\n\t\t\t\t2018110508353551000_bb0385","doi-asserted-by":"crossref","first-page":"9","DOI":"10.3322\/canjclin.40.1.9","article-title":"Cancer statistics, 1990","volume":"40","author":"Silverberg","year":"1990","journal-title":"CA Cancer J Clin"},{"key":"key\n\t\t\t\t2018110508353551000_bb0390","doi-asserted-by":"crossref","first-page":"1224","DOI":"10.1046\/j.1365-2133.2000.03892.x","article-title":"Changing trends in non-melanoma skin cancer in South Wales, 1988-98","volume":"143","author":"Holme","year":"2000","journal-title":"Br J Dermatol"},{"key":"key\n\t\t\t\t2018110508353551000_bb0395","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1001\/archderm.1997.03890420073008","article-title":"Trends in the population-based incidence of squamous cell carcinoma of the skin first diagnosed between 1984 and 1992","volume":"133","author":"Gray","year":"1997","journal-title":"Arch Dermatol"},{"key":"key\n\t\t\t\t2018110508353551000_bb0400","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1002\/(SICI)1097-0215(19981123)78:5<587::AID-IJC10>3.0.CO;2-E","article-title":"Incidence rates of skin cancer in Townsville, Australia","volume":"78","author":"Buettner","year":"1998","journal-title":"Int J Cancer"},{"key":"key\n\t\t\t\t2018110508353551000_bb0405","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1111\/j.1365-2133.2005.06799.x","article-title":"Skin cancer incidence and the ageing population","volume":"153","author":"Diffey","year":"2005","journal-title":"Br J Dermatol"},{"key":"key\n\t\t\t\t2018110508353551000_bb0410","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1016\/j.jaad.2006.08.039","article-title":"Basal cell carcinoma on the trunk is associated with excessive sun exposure","volume":"56","author":"Neale","year":"2007","journal-title":"J Am Acad Dermatol"},{"key":"key\n\t\t\t\t2018110508353551000_bb0415","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1016\/S0140-6736(88)91658-3","article-title":"Malignant transformation of solar keratoses to squamous cell carcinoma","volume":"1","author":"Marks","year":"1988","journal-title":"Lancet"},{"key":"key\n\t\t\t\t2018110508353551000_bb0420","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1023\/A:1018440801577","article-title":"Sunlight and cancer","volume":"8","author":"English","year":"1997","journal-title":"Cancer Causes Control"},{"key":"key\n\t\t\t\t2018110508353551000_bb0425","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1002\/ijc.2910600410","article-title":"A dose-response curve for sun exposure and basal cell carcinoma","volume":"60","author":"Kricker","year":"1995","journal-title":"Int J Cancer"},{"key":"key\n\t\t\t\t2018110508353551000_bb0430","doi-asserted-by":"crossref","first-page":"1440","DOI":"10.1038\/bjc.1996.274","article-title":"The multicentre south European study 'Helios'. I: Skin characteristics and sunburns in basal cell and squamous cell carcinomas of the skin","volume":"73","author":"Zanetti","year":"1996","journal-title":"Br J Cancer"},{"key":"key\n\t\t\t\t2018110508353551000_bb0435","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1111\/j.1365-2133.2005.06537.x","article-title":"The photocarcinogenic risk of narrowband UVB (TL-01) phototherapy: early follow-up data","volume":"152","author":"Man","year":"2005","journal-title":"Br J Dermatol"},{"key":"key\n\t\t\t\t2018110508353551000_bb0440","doi-asserted-by":"crossref","first-page":"1588","DOI":"10.1200\/JCO.2011.39.3652","article-title":"Use of tanning beds and incidence of skin cancer","volume":"30","author":"Zhang","year":"2012","journal-title":"J Clin Oncol"},{"key":"key\n\t\t\t\t2018110508353551000_bb0445","doi-asserted-by":"crossref","first-page":"1276","DOI":"10.1038\/sj.bjc.6604665","article-title":"PTCH mutations in basal cell carcinomas from azathioprine-treated organ transplant recipients","volume":"99","author":"Harwood","year":"2008","journal-title":"Br J Cancer"},{"key":"key\n\t\t\t\t2018110508353551000_bb0450","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1093\/jnci\/djj092","article-title":"Human papillomavirus infection and incidence of squamous cell and basal cell carcinomas of the skin","volume":"98","author":"Karagas","year":"2006","journal-title":"J Natl Cancer Inst"},{"key":"key\n\t\t\t\t2018110508353551000_bb0455","doi-asserted-by":"crossref","first-page":"1355","DOI":"10.1038\/jid.2008.123","article-title":"Beta-papillomavirus infection and skin cancer","volume":"128","author":"Bouwes Bavinck","year":"2008","journal-title":"J Invest Dermatol"},{"key":"key\n\t\t\t\t2018110508353551000_bb0460","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1111\/j.1365-2133.2005.07021.x","article-title":"A population-based study of skin cancer incidence and prevalence in renal transplant recipients","volume":"154","author":"Moloney","year":"2006","journal-title":"Br J Dermatol"},{"key":"key\n\t\t\t\t2018110508353551000_bb0465","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1016\/j.cgh.2009.11.024","article-title":"Increased risk for non-melanoma skin cancer in patients with inflammatory bowel disease","volume":"8","author":"Long","year":"2010","journal-title":"Clin Gastroenterol Hepatol"},{"key":"key\n\t\t\t\t2018110508353551000_bb0470","doi-asserted-by":"crossref","first-page":"1612","DOI":"10.1053\/j.gastro.2011.07.039","article-title":"Increased risk of nonmelanoma skin cancers among individuals with inflammatory bowel disease","volume":"141","author":"Singh","year":"2011","journal-title":"Gastroenterology"},{"key":"key\n\t\t\t\t2018110508353551000_bb0475","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1093\/annonc\/mdn595","article-title":"Cancer risks in Crohn disease patients","volume":"20","author":"Hemminki","year":"2009","journal-title":"Ann Oncol"},{"key":"key\n\t\t\t\t2018110508353551000_bb0480","doi-asserted-by":"crossref","first-page":"1443","DOI":"10.1038\/ajg.2012.181","article-title":"Risk of melanoma in patients who receive thiopurines for inflammatory bowel disease is not increased","volume":"107","author":"Peyrin-Biroulet","year":"2012","journal-title":"Am J Gastroenterol"},{"key":"key\n\t\t\t\t2018110508353551000_bb0485","doi-asserted-by":"crossref","first-page":"2581","DOI":"10.1158\/1078-0432.CCR-03-0638","article-title":"Etiologic pathogenesis of melanoma: a unifying hypothesis for the missing attributable risk","volume":"10","author":"Meyskens","year":"2004","journal-title":"Clin Cancer Res"},{"key":"key\n\t\t\t\t2018110508353551000_bb0490","doi-asserted-by":"crossref","first-page":"2103","DOI":"10.1038\/sj.jid.5700988","article-title":"How different wavelengths of the ultraviolet spectrum contribute to skin carcinogenesis: the role of cellular damage responses","volume":"127","author":"Runger","year":"2007","journal-title":"J Invest Dermatol"},{"key":"key\n\t\t\t\t2018110508353551000_bb0495","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1080\/09553000902740150","article-title":"Cellular and sub-cellular responses to UVA in relation to carcinogenesis","volume":"85","author":"Ridley","year":"2009","journal-title":"Int J Radiat Biol"},{"key":"key\n\t\t\t\t2018110508353551000_bb0500","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1097\/CEJ.0b013e3282b6fcff","article-title":"Antitumor necrosis factor-alpha therapy and potential cancer inhibition","volume":"17","author":"Williams","year":"2008","journal-title":"Eur J Cancer Prev"},{"key":"key\n\t\t\t\t2018110508353551000_bb0505","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1046\/j.1365-2133.2002.04804.x","article-title":"Variations of basal cell carcinomas according to age, gender, location and histopathological subtype","volume":"147","author":"Scrivener","year":"2002","journal-title":"Br J Dermatol"},{"key":"key\n\t\t\t\t2018110508353551000_bb0510","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1067\/mjd.2002.125579","article-title":"Skin cancer in organ transplant recipients: epidemiology, pathogenesis, and management","volume":"47","author":"BDaC","year":"2002","journal-title":"J Am Acad Dermatol"},{"key":"key\n\t\t\t\t2018110508353551000_bb0515","first-page":"1524","article-title":"Risk of developing a subsequent nonmelanoma skin cancer in patients with a history of nonmelanoma skin cancer: a critical review of the literature and meta-analysis","volume":"136","author":"MIaR","year":"2000","journal-title":"Arch Dermatol"},{"key":"key\n\t\t\t\t2018110508353551000_bb0520","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1111\/j.1524-4725.1989.tb03166.x","article-title":"Long-term recurrence rates in previously untreated (primary) basal cell carcinoma: implications for patient follow-up","volume":"15","author":"Rowe","year":"1989","journal-title":"J Dermatol Surg Oncol"}],"container-title":["Journal of Crohn's and Colitis"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/api.elsevier.com\/content\/article\/PII:S1873994613001451?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/api.elsevier.com\/content\/article\/PII:S1873994613001451?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/academic.oup.com\/ecco-jcc\/article-pdf\/8\/1\/31\/26359775\/8-1-31.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,7,14]],"date-time":"2019-07-14T01:16:36Z","timestamp":1563066996000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/ecco-jcc\/article\/8\/1\/31\/1820779"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,1,1]]},"references-count":104,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2014,1,1]]},"published-print":{"date-parts":[[2014,1,1]]}},"URL":"https:\/\/doi.org\/10.1016\/j.crohns.2013.04.006","relation":{},"ISSN":["1876-4479","1873-9946"],"issn-type":[{"value":"1876-4479","type":"electronic"},{"value":"1873-9946","type":"print"}],"subject":[],"published-other":{"date-parts":[[2014,1]]},"published":{"date-parts":[[2014,1,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Extra-intestinal malignancies in inflammatory bowel disease: Results of the 3rd ECCO Pathogenesis Scientific Workshop (III)","name":"articletitle","label":"Article Title"},{"value":"Journal of Crohn's and Colitis","name":"journaltitle","label":"Journal Title"},{"value":"http:\/\/dx.doi.org\/10.1016\/j.crohns.2013.04.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2013 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}]}}